Insight Molecular Diagnostics Inc. PP&E Disclosure
ROU operating and financing lease assets, net, machinery and equipment, net, and construction in progress were as follows:
|
|
December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
|
|
(In thousands) |
|
|||||
ROU operating and financing lease assets |
|
$ |
5,623 |
|
|
$ |
5,323 |
|
Machinery, equipment and leasehold improvements |
|
|
12,516 |
|
|
|
8,366 |
|
Accumulated depreciation and amortization |
|
|
(9,654 |
) |
|
|
(7,705 |
) |
|
|
|
8,485 |
|
|
|
5,984 |
|
Construction in progress |
|
|
765 |
|
|
|
340 |
|
Property and equipment, net |
|
$ |
9,250 |
|
|
$ |
6,324 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 26, 2026 | Showing above |
| 2024 | Mar 24, 2025 | |
| 2023 | Apr 16, 2024 | |
About PP&E Disclosures
The PP&E disclosure details a company's physical asset base — land, buildings, machinery, and equipment — along with the depreciation methods and useful life assumptions that determine how these costs flow through the income statement. Capitalization policy thresholds reveal management's judgment on the boundary between expense and asset, directly affecting both reported earnings and asset values.
Key signals: changes in estimated useful lives or depreciation methods can materially shift reported earnings without any operational change. Compare capital expenditures against depreciation expense — when capex consistently trails depreciation, the asset base may be aging and underinvested. Watch for large asset impairments or write-downs that signal overvalued carrying amounts. Asset retirement obligations reveal future environmental or decommissioning costs that are often underappreciated. Compare PP&E intensity (PP&E-to-revenue) against industry peers to assess capital efficiency and competitive positioning.